Business Description
Jyong Biotech Ltd
ISIN : KYG831161065
Total Employee Number:
27Description
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -1.2 | |||||
Debt-to-Equity | -0.75 | |||||
Debt-to-EBITDA | -8.7 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.3 | |||||
3-Year EPS without NRI Growth Rate | 11.6 | |||||
3-Year Book Growth Rate | 4.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 69.99 | |||||
9-Day RSI | 64.06 | |||||
14-Day RSI | 58.04 | |||||
3-1 Month Momentum % | -9.65 | |||||
6-1 Month Momentum % | -47.85 | |||||
12-1 Month Momentum % | -75.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | -17.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -21.62 | |||||
ROIC % | -9.68 | |||||
3-Year ROIIC % | -17.93 | |||||
ROC (Joel Greenblatt) % | -65.32 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 10.28 | |||||
EV-to-EBIT | -86.49 | |||||
EV-to-EBITDA | -86.49 | |||||
EV-to-FCF | -216.69 | |||||
Earnings Yield (Greenblatt) % | -1.16 | |||||
FCF Yield % | -0.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MENS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jyong Biotech Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.06 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 258 | ||
| 14-Day RSI | 58.04 | ||
| 14-Day ATR ($) | 0.218453 | ||
| 20-Day SMA ($) | 1.8245 | ||
| 12-1 Month Momentum % | -75.71 | ||
| 52-Week Range ($) | 1.43 - 67 | ||
| Shares Outstanding (Mil) | 74.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jyong Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jyong Biotech Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-18 | In 139 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 43 days | ||
| General meeting for 2025 | 2026-07-14 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-07-03 | In 1 day | ||
| Annual report for 2025 | 2026-05-15 | 2.08 (+1.46%) |
Show
Entries
Jyong Biotech Ltd Frequently Asked Questions
What is Jyong Biotech Ltd(MENS)'s stock price today?
The current price of MENS is $2.25. The 52 week high of MENS is $67.00 and 52 week low is $1.43.
When is next earnings date of Jyong Biotech Ltd(MENS)?
The next earnings date of Jyong Biotech Ltd(MENS) is 2026-07-03 Est..
Does Jyong Biotech Ltd(MENS) pay dividends? If so, how much?
Jyong Biotech Ltd(MENS) does not pay dividend.
Guru Commentaries on NAS:MENS
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jyong Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers